Medications for Acute Coronary Syndromes
KEYWORDS: patients, orally, risk, heparin, pci, day, used, hours, bleeding, given, nitroglycerin, therapy, coronary, use, acs

in patients who cannot tolerate aspirin, alone For elective PCI, maintenance therapy 75 mg orally once a day required for at least 1 For patients undergoing month for bare-metal PCI: 300–600 mg orally Clopidogrel stents and for at least 6– once, then 75 mg orally 12 months for drug-eluting once a day for 1–12 stents months For ACS, dual antiplatelet therapy (typically with aspirin) is recommended for at least 12 months (for any type of stent) Prasugrel 60 mg orally once before Only for patients with ACS PCI, followed by 10 mg undergoing PCI Medication Dosage Use orally once a day for 1–12 Not used in combination months with fibrinolytic therapy For patients undergoing PCI: 180 mg orally once before the procedure, Ticagrelor — followed by 90 mg orally twice a day for 1–12 months Rarely used routinely because neutropenia is a 250 mg orally twice a day Ticlopidine risk and white blood cell for 1–12 months count must be monitored regularly Beta-blockers All patients with ACS, unless a beta-blocker is Atenolol Variable† not tolerated or is contraindicated, especially high-risk patients; used long-term Bisoprolol Variable† Intravenous beta-blockers may be used in patients with ongoing chest pain despite usual measures, or
